Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

xTAG Cystic Fibrosis 39 Kit v2

K-Number: K163347 · 2016-12-15

Decision Date2016-12-15
Product CodeNUA
Advisory CommitteeIM
DecisionUnknown

Device Summary

xTAG Cystic Fibrosis 39 Kit v2 is the device name listed in this FDA 510(k) record. The listed applicant is Luminex Molecular Diagnostics, Inc.. It received FDA 510(k) clearance on 2016-12-15 under 510(k) number K163347. The device is classified under product code NUA. It was reviewed by the IM advisory panel. FDA Decision: Unknown.

Frequently Asked Questions

What is the xTAG Cystic Fibrosis 39 Kit v2?

xTAG Cystic Fibrosis 39 Kit v2 is a medical device that received FDA 510(k) clearance on 2016-12-15. The listed applicant is Luminex Molecular Diagnostics, Inc.. The 510(k) number is K163347.

When did xTAG Cystic Fibrosis 39 Kit v2 receive FDA 510(k) clearance?

xTAG Cystic Fibrosis 39 Kit v2 received FDA 510(k) clearance on 2016-12-15, under 510(k) number K163347.

Who is the listed applicant for xTAG Cystic Fibrosis 39 Kit v2?

The FDA 510(k) record lists Luminex Molecular Diagnostics, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for xTAG Cystic Fibrosis 39 Kit v2?

The FDA product code for xTAG Cystic Fibrosis 39 Kit v2 is NUA.

Other records listing Luminex Molecular Diagnostics, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

View all 10 devices →

Related Devices (Code: NUA)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.